Corona Remedies (CORONA)

FAST GROWER

FairStock Score: 23/100 — RISKY

Score breakdown: P/E: 0/3 · ROCE: 2/2 · Growth: 2/2 · Dividend: 0/1

Key Financials

Current Price₹1,640.75
Market Cap₹9,707.33 Cr
P/E Ratio60.96
ROCE31.47%
ROE—%
Dividend Yield0%
Profit Growth21.58%
Debt/Equity0.1
Sales Growth15.03%
Promoter Holding69%
52-Week Range₹1,336.6 — ₹1,951.3
SectorPharmaceuticals & Biotechnology
Book Value₹107.8

Corona Remedies trades with a P/E ratio of 60.96, ROCE of 31.47%, profit growth of 21.58%, debt-to-equity of 0.1. The FairStock Score of 23/100 flags concerns across multiple fundamental dimensions that investors should examine carefully.

Data from BSE/NSE filings. AI analysis is for educational purposes only — not investment advice. Scoring methodology · Disclaimer